Nafithromycin was developed over a 14‑year effort by Wockhardt, involving collaboration across the US, Europe, South Africa, and India, backed by approximately INR 500 crore. It belongs to a new class called lactone‑ketolides and aims to address resistant respiratory infections. Phase I trials confirmed safety and how it behaves in the body, followed by Phase II and III studies comparing it to standard antibiotics in adults with community‑acquired pneumonia (CABP). In January 2025, India’s CDSCO approved it (marketed as Miqnaf) for adult CABP in a convenient once‑daily, 3‑day oral course.

Nafithromycin is used to treat:

• Community‑acquired bacterial pneumonia

• Acute bacterial exacerbation of chronic bronchitis

• Acute bacterial sinusitis

• Streptococcal pharyngitis/tonsillitis

Nafithromycin comes as oral tablets of 400 mg. The approved dose for pneumonia and similar infections in adults is one 400 mg tablet once a day, usually for three days. Its design ensures a full treatment effect with just one daily tablet, enhancing convenience and increasing chances that patients complete the course.

Common (usually mild and temporary):

• Mild stomach discomfort or nausea

• Headache or dizziness

• Loose stools or mild diarrhoea

• Temporary skin rash

Serious (less common, seek medical help):

• Severe allergic reactions (swelling, hives, trouble breathing)

• Irregular heartbeat or feeling of a fast pulse

• Intense gastrointestinal symptoms (severe cramps, persistent vomiting)

Most people tolerate the medicine well, but any unexpected or worsening symptoms should be reported right away.

• Not to be used by those with known allergy to macrolide or ketolide antibiotics.

• May interact with strong heart rhythm medicines; check with your doctor.

• Caution in those with heart rhythm issues; a heart monitor may be needed.

• Avoid taking certain liver‑metabolism inhibitors, can affect drug levels and safety.

• Not studied in children or pregnant women, usage in these cases needs medical advice.

Before starting, tell your doctor about any heart issues, especially those prone to irregular rhythms, or if you’re using medicines that affect liver enzymes (like certain antifungals or antivirals). The drug builds up in the lungs, so people with liver or kidney problems may need close observation. As with all antibiotics, finish the full prescribed course even if you start to feel better, as this helps fight resistance.

• Take each dose at the same time every day to maintain steady levels.

• You can take it with or without food; it doesn’t require meals.

• Stick to the full three‑day course—cutting short can let bacteria survive.

• Avoid combining it with other antibiotics unless directed by your doctor.

• Watch for signs of allergy or heart rhythm changes, and report them immediately.

1. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2081506 

2. https://pmc.ncbi.nlm.nih.gov/articles/PMC8210042/

3. https://www.sciencedirect.com/science/article/pii/S2211715622004763

The content provided here is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition.